BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8578312)

  • 1. The etiopathogenesis of Sjögren's syndrome.
    Price EJ; Venables PJ
    Semin Arthritis Rheum; 1995 Oct; 25(2):117-33. PubMed ID: 8578312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sjögren's syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects.
    Mavragani CP; Tzioufas AG; Moutsopoulos HM
    Int Arch Allergy Immunol; 2000 Sep; 123(1):46-57. PubMed ID: 11014971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-I associated Sjögren's syndrome is aetiologically distinct from anti-centromere antibodies positive Sjögren's syndrome.
    Hida A; Kawabe Y; Kawakami A; Migita K; Tominaga M; Nakamura H; Eguchi K
    Ann Rheum Dis; 1999 May; 58(5):320-2. PubMed ID: 10225819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sjögren's syndrome. Yes autoreactive lymphocytes, why? Virus or gene?
    Sawada S; Takei M
    Intern Med; 2002 Feb; 41(2):75-6. PubMed ID: 11868610
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome.
    Harley JB; Alexander EL; Bias WB; Fox OF; Provost TT; Reichlin M; Yamagata H; Arnett FC
    Arthritis Rheum; 1986 Feb; 29(2):196-206. PubMed ID: 3485431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sjögren's syndrome--a house of cards.
    Isenberg D
    Clin Rheumatol; 1995 Jul; 14 Suppl 1():8-10. PubMed ID: 7493453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
    Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
    Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of HLA class II genes and autoimmune responses to Ro/SS-A-La/SS-B among Japanese subjects.
    Miyagawa S; Shinohara K; Nakajima M; Kidoguchi K; Fujita T; Fukumoto T; Yoshioka A; Dohi K; Shirai T
    Arthritis Rheum; 1998 May; 41(5):927-34. PubMed ID: 9588746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sjögren Syndrome without Focal Lymphocytic Infiltration of the Salivary Glands.
    Sharma R; Chaudhari KS; Kurien BT; Grundahl K; Radfar L; Lewis DM; Lessard CJ; Li H; Rasmussen A; Sivils KL; Scofield RH
    J Rheumatol; 2020 Mar; 47(3):394-399. PubMed ID: 31092717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive transfer of antibodies to the linear epitope 60 kD Ro 273-289 induces features of Sjögren's syndrome in naive mice.
    Maier-Moore JS; Kurien BT; D'Souza A; Bockus L; Asfa S; Dorri Y; Hubbell S; Yeliosof O; Obeso D; Schoeb TR; Jonsson R; Scofield RH
    Clin Exp Immunol; 2015 Apr; 180(1):19-27. PubMed ID: 25370295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ro/SS-A and La/SS-B: autoantigens in Sjögren's syndrome?
    Smeenk RJ
    Clin Rheumatol; 1995 Jul; 14 Suppl 1():11-6. PubMed ID: 7493450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between autoantibodies and clinical parameters in Sjögren's syndrome.
    Tsuzaka K; Ogasawara T; Tojo T; Fujii H; Tsukatani Y; Kubo A; Homma M
    Scand J Rheumatol; 1993; 22(1):1-9. PubMed ID: 8381986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
    Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
    Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies and their target antigens in Sjögren's syndrome.
    Meilof JF; Smeenk RJ
    Neth J Med; 1992 Apr; 40(3-4):140-7. PubMed ID: 1603204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological and immunogenetic markers of extraglandular primary Sjögren's syndrome.
    Pease CT; Charles PJ; Shattles W; Markwick J; Maini RN
    Br J Rheumatol; 1993 Jul; 32(7):574-7. PubMed ID: 8339127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome.
    Tengnér P; Halse AK; Haga HJ; Jonsson R; Wahren-Herlenius M
    Arthritis Rheum; 1998 Dec; 41(12):2238-48. PubMed ID: 9870881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sjögren's syndrome. Controversies and progress.
    Fox RI
    Clin Lab Med; 1997 Sep; 17(3):431-44. PubMed ID: 9316767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and serologic study of Sjögren's syndrome in patients with progressive systemic sclerosis.
    Osial TA; Whiteside TL; Buckingham RB; Singh G; Barnes EL; Pierce JM; Rodnan GP
    Arthritis Rheum; 1983 Apr; 26(4):500-8. PubMed ID: 6838673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination between Sjögren's and non-Sjögren's sicca syndrome by sialoscintigraphy and antibodies against alpha-fodrin and Ro/La autoantigens.
    Chen KS; Jiang MC; Li CJ; Liu OK; Tsai CS
    J Int Med Res; 2009; 37(4):1088-96. PubMed ID: 19761691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Ro(SSA) 52 kDa reactive T cells in labial salivary glands from patients with Sjögren's syndrome.
    Namekawa T; Kuroda K; Kato T; Yamamoto K; Murata H; Sakamaki T; Nishioka K; Iwamoto I; Saitoh Y; Sumida T
    J Rheumatol; 1995 Nov; 22(11):2092-9. PubMed ID: 8596150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.